Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys
about
Ustekinumab for the treatment of Crohn's disease.Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice.Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials.
P2860
Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterizing unmet medical n ...... c review and clinician surveys
@ast
Characterizing unmet medical n ...... c review and clinician surveys
@en
Characterizing unmet medical n ...... c review and clinician surveys
@nl
type
label
Characterizing unmet medical n ...... c review and clinician surveys
@ast
Characterizing unmet medical n ...... c review and clinician surveys
@en
Characterizing unmet medical n ...... c review and clinician surveys
@nl
prefLabel
Characterizing unmet medical n ...... c review and clinician surveys
@ast
Characterizing unmet medical n ...... c review and clinician surveys
@en
Characterizing unmet medical n ...... c review and clinician surveys
@nl
P2093
P2860
P31
P921
P1476
Characterizing unmet medical n ...... c review and clinician surveys
@en
P2093
Andy Maguire
Daniel M. Sugrue
Jason P. Gordon
Jorge Puelles
Phil C. McEwan
P2860
P304
P356
10.1097/MEG.0000000000000378
P407
P5008
P577
2015-07-01T00:00:00Z